追加説明:
A hyaluronic acid viscosupplement injection containing 5 mL of sodium hyaluronate, indicated for knee osteoarthritis via a single intra-articular injection. Described as a novel cross-linked hydrogel and best-in-class, with Phase III completed in Q4 2022.
評価とコメントを残す